Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting10-05-2024
10-05-2024
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached the invite of the Conference Call for Investors/ Analysts to be held on Friday, May 10, 2024 at 03.30 P.M. (IST) to discuss the financial and operating performance for Q4 & FY24.03-05-2024
Dr. Lal PathLabs Ltd - 539524 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Certificate attached for financial year ended March 31, 202403-05-2024
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for Consideration And Approval Of The Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024 And To Consider Recommending Final Dividend, If Any
Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial year ended March 31, 2024 and to consider recommending Final Dividend, if any03-05-2024
Dr. Lal PathLabs Ltd - 539524 - Update On Resignation Of Mr. Bharath U, Chief Executive Officer (Key Managerial Personnel)
Disclosure on update on Resignation of Mr. Bharath U is attached26-04-2024
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Disclosure under Regulation 30- Newspaper Publication24-04-2024